NRC (NRC Health Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by NRC officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-25 | Donald M Berwick | Director | A | — | — |
| 2026-06-25 | Parul Bhandari | Director | A | — | — |
| 2026-06-25 | Stephen H Lockhart | Director | A | — | — |
| 2026-06-25 | Penny Ann Wheeler | Director | A | — | — |
| 2026-06-25 | JOHN N NUNNELLY | Director | A | — | — |
| 2026-03-13 | Jason Russell Rau | Executive Vice President | A | — | — |
| 2026-02-19 | SHANE R HARRISON | EVP & Chief Financial Officer | Buy | — | — |
| 2026-02-17 | Parul Bhandari | Director | A | — | — |
| 2026-02-17 | Stephen H Lockhart | Director | A | — | — |
| 2026-01-26 | SHANE R HARRISON | EVP & Chief Financial Officer | F | — | — |
| 2026-01-16 | David Burik | EVP, Strategic Insights | A | — | — |
| 2026-01-07 | Michael D. Hays | Chairman | M | — | — |
| 2025-12-17 | Helen Hrdy | EVP & Chief Operating Officer | MIXED | — | — |
| 2025-10-21 | JOHN N NUNNELLY | Director | A | — | — |
| 2025-10-21 | Donald M Berwick | Director | A | — | — |
| 2025-10-21 | Penny Ann Wheeler | Director | A | — | — |
| 2025-10-01 | SHANE R HARRISON | EVP & Chief Financial Officer | A | — | — |
| 2025-08-04 | Jordan Nicole Freeman | Chief Accounting Officer | Buy | — | — |
| 2025-06-03 | Trent S Green | Chief Executive Officer | A | — | — |
| 2025-05-13 | PATRICK E BEANS | 10%+ Owner | Buy | — | — |
| 2025-05-09 | Donald M Berwick | Director | A | — | — |
| 2025-05-09 | Penny Ann Wheeler | Director | A | — | — |
| 2025-05-09 | Stephen H Lockhart | Director | A | — | — |
| 2025-05-09 | Parul Bhandari | Director | A | — | — |
| 2025-05-09 | JOHN N NUNNELLY | Director | A | — | — |
| 2025-04-10 | PATRICK E BEANS | 10%+ Owner | G | — | — |
| 2025-04-10 | Amandla MK Trust | 10%+ Owner | G | — | — |
| 2025-04-10 | Common Property Trust | 10%+ Owner | G | — | — |
| 2025-04-09 | Helen Hrdy | Chief Operating Officer | A | — | — |
| 2025-04-09 | Andrew Monnich | Chief Corp. Development Off. | A | — | — |
| 2025-01-14 | Michael D. Hays | CEO & President | A | — | — |
| 2025-01-06 | Michael D. Hays | CEO & President | M | — | — |
| 2024-05-10 | Donald M Berwick | Director | A | — | — |
| 2024-05-10 | Parul Bhandari | Director | A | — | — |
| 2024-05-10 | Stephen H Lockhart | Director | A | — | — |
| 2024-05-10 | Penny Ann Wheeler | Director | A | — | — |
| 2024-05-10 | JOHN N NUNNELLY | Director | A | — | — |
| 2024-03-29 | JOHN N NUNNELLY | Director | MIXED | — | — |
| 2024-03-05 | Common Property Trust | 10%+ Owner | Sell | — | — |
| 2024-01-08 | Amandla MK Trust | 10%+ Owner | Sell | — | — |
| 2024-01-05 | Common Property Trust | 10%+ Owner | Sell | — | — |
| 2024-01-04 | Amandla MK Trust | 10%+ Owner | Sell | — | — |
| 2024-01-04 | Michael D. Hays | CEO & President | MIXED | — | — |
| 2023-12-14 | Amandla MK Trust | 10%+ Owner | Sell | — | — |
| 2023-12-11 | Amandla MK Trust | 10%+ Owner | Sell | — | — |
| 2023-12-06 | Amandla MK Trust | 10%+ Owner | Sell | — | — |
| 2023-11-22 | Amandla MK Trust | 10%+ Owner | Sell | — | — |
| 2023-11-17 | Amandla MK Trust | 10%+ Owner | Sell | — | — |
| 2023-10-13 | Amandla MK Trust | 10%+ Owner | Sell | — | — |
| 2023-06-27 | Amandla MK Trust | 10%+ Owner | Sell | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 5,388,634 | — |
| — | 10%+ Owner | 4,755,317 | — |
| — | Chief Executive Officer | 500,000 | — |
| — | EVP & Chief Financial Officer | 158,729 | — |
| — | EVP & Chief Operating Officer | 151,762 | — |
| — | Director | 143,955 | — |
| — | EVP, Strategic Insights | 100,000 | — |
| — | Chief Corp. Development Off. | 100,000 | — |
| — | Chairman | 96,249 | — |
| — | Executive Vice President | 60,000 | — |
| — | President | 55,567 | — |
| — | Director | 42,902 | — |
| — | Director | 40,363 | — |
| — | 10%+ Owner | 35,003 | — |
| — | COO, NRC Health | 12,951 | — |
| — | Director | 7,697 | — |
| — | Director | 7,697 | — |
| — | Director | 7,697 | — |
| — | Director | 7,697 | — |
| — | SVP Finance, CFO, Treas & Secy | 5,384 | — |
| — | Chief Accounting Officer | 771 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the NRC quote page; the site-wide leaderboard is on the insider transactions hub.